ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement

March 18, 1994

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980

NCI Begins TAILORx Study.

May 26, 2006

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987